How do I buy shares of Tetra Bio-Pharma?

Shares of TBPMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:TBPMF

Tetra Bio-Pharma (TBPMF) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free TBPMF Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: 185,753 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart

Get Tetra Bio-Pharma alerts:

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About Tetra Bio-Pharma Stock (OTCMKTS:TBPMF)

Tetra Bio-Pharma Inc., a biopharmaceutical company, engages in the discovery and development of cannabinoid-derived drugs for inflammation, pain, ophthalmology, and oncology. The company develops PLENITUDE to treat cancer-related pain in advanced cancer patients; REBORN for the treatment of breakthrough cancer pain; Reduvo for chemotherapy-induced nausea and vomiting; ARDS-003 for the treatment of sepsis and prevention of acute respiratory distress syndrome; and SERENITY to treat cancer cachexia. It also develops PPP003 for painful dry eye and uveitis pain; and HCC011 for hepatocellular carcinoma. Tetra Bio-Pharma Inc. has an agreement with Cellvera Global Holdings LLC for the co-development of ARDS-003 as a combination product with Qifenda 400MG (Favipiravir), a commercial-stage broad-spectrum antiviral drug. The company is headquartered in Orléans, Canada.

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

TBPMF Stock News Headlines

March 16, 2024 | benzinga.com

Latest News for First Wave BioPharma Stock (NASDAQ:FWBI)

August 1, 2023 | seekingalpha.com

Tetra Bio-Pharma files for bankruptcy in Canada

April 18, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

May 12, 2023 | marketwatch.com

Tetra Bio-Pharma Cancels New Drug Submission to Health Canada

April 28, 2023 | theglobeandmail.com

Closing Bell: Tetra Bio Pharma Inc flat on Wednesday (TBP)

April 27, 2023 | theglobeandmail.com

Closing Bell: Tetra Bio Pharma Inc flat on Tuesday (TBP)

April 25, 2023 | theglobeandmail.com

Closing Bell: Tetra Bio Pharma Inc flat on Monday (TBP)

April 18, 2023 | theglobeandmail.com

Closing Bell: Tetra Bio Pharma Inc flat on Friday (TBP)

April 18, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

April 15, 2023 | theglobeandmail.com

Closing Bell: Tetra Bio Pharma Inc flat on Thursday (TBP)

April 9, 2023 | theglobeandmail.com

Closing Bell: Tetra Bio-Pharma Inc flat on Wednesday (TBP-WT-C)

March 7, 2023 | finance.yahoo.com

IIROC Trading Halt - TBP

March 3, 2023 | finance.yahoo.com

Tetra Bio-Pharma Receives Funding from the Government of Canada for ARDS-003

March 1, 2023 | finance.yahoo.com

Tetra Bio-Pharma Inc. Announces a Delay in Filing 2022 Annual Financial Statements and Related Management's Discussion and Analysis

February 28, 2023 | ca.finance.yahoo.com

Tetra Bio-Pharma Inc. (TBP.TO)

February 19, 2023 | marketwatch.com

Bio-pharma Market 2023: A Status of Top Regions and Companies with Growth Prospects

February 14, 2023 | finance.yahoo.com

IIROC Trading Halt - TBP.WT.B

December 22, 2022 | prnewswire.com

REDUVO™ Marketing Approval on the Right Path

December 6, 2022 | finance.yahoo.com

Tetra Bio-Pharma Announces Results of Artificial Intelligence Study of ARDS-003 Combined with Favipiravir

November 30, 2022 | finance.yahoo.com

The Power Play by The Market Herald Releases New Interviews with Group Eleven, iMining, Gamelancer, Cassiar Gold, ApartmentLove, Tetra Bio-Pharma and Sitka Gold Discussing Their Latest News

November 29, 2022 | finance.yahoo.com

Tetra Bio-Pharma Provides Update on Patent Applications for Novel Therapeutic ARDS-003

October 28, 2022 | benzinga.com

Tetra Bio-Pharma Anounces Second Closing Of Financing With Alpha Blue Ocean

October 28, 2022 | msn.com

Tetra Bio-Pharma Announces Second Closing Of Financing With Alpha Blue Ocean

October 27, 2022 | finance.yahoo.com

Tetra Bio-Pharma Inc. Announces Second Closing of Financing with Alpha Blue Ocean

October 13, 2022 | marketwatch.com

Tetra Bio-Pharma Inc. (TBPMF) and Prepaire Jointly Apply to BARDA for Funding

October 11, 2022 | finance.yahoo.com

Tetra and Prepaire Jointly Apply to BARDA for Funding

September 8, 2022 | finance.yahoo.com

Tetra Bio-Pharma Inc. Announces Revised Terms and First Closing of Financing with Alpha Blue Ocean

See More Headlines

Receive TBPMF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tetra Bio-Pharma and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: OTCMKTS:TBPMF
CUSIP: N/A
CIK: N/A
Web: www.tetrabiopharma.com
Phone: (833) 977-7575
Fax: N/A
Employees: 33
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

Dr. Guy Chamberland M.Sc. (Age 61)
Master Herbal, Co-Founder, CEO, Chief Regulatory Officer & Director
Comp: $239.98k
Mr. Steeve Néron
Chief Commercial Officer
Mr. André Rancourt B.Sc.
Co-Founder
Ms. Leslie Auld CPA
M.B.A., Chief Financial Officer
Jennifer McCaughey
VP of Investor Relations
Ms. Dania Scott B.Sc.
Sr. VP of Commercial Strategy
Ms. Aurelia De Pauw
Sr. VP of Clinical Programs & Medical Affairs
Mr. Richard Giguere
Chief Exec. Officer of Tetra Natural Health Inc.
Randy Ringuette
Project Director & Member of Advisory Board
Mr. Chris MacLean
Chief Operating Officer of Tetra Natural Health

Key Competitors

View All Competitors

TBPMF Stock Analysis - Frequently Asked Questions

How do I buy shares of Tetra Bio-Pharma?: Shares of TBPMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:TBPMF) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Tetra Bio-Pharma (TBPMF) Stock Price, News & Analysis

About Tetra Bio-Pharma Stock (OTCMKTS:TBPMF)

TBPMF Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

TBPMF Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info